Understanding and Defeating COVID-19: Diagnostic Tactics and Access to Medical Care

28 April 2020

Understanding and Defeating COVID-19: Diagnostic Tactics and Access to Medical Care 

The roundtable ‘Understanding and Defeating COVID-19: Diagnostic Tactics and Access to Medical Care’ will be broadcast live on 29 April 2020 at 18:30 Moscow Time. The event is organized by the Content Foundation for the Development of Expert and Analytical Activity and the Roscongress Foundation. News Channel Russia 24 will serve as event’s information partner. 

Other countries’ experience in facing this epidemic has shown that mass testing and the most complete identification of all infected persons and their temporary isolation is the only viable strategy for limiting the spread of the coronavirus epidemic. China – who has successfully slowed the spread of their epidemic – has demonstrated the effectiveness of using computer tomography (CT) in addition to the traditional polymerase chain reaction (PCR) method to identify the largest number of ‘confirmed infected’ individuals, efficiently manage infection sources, and effectively cut off transmission vectors. 
Russia has the potential to comprehensively test its citizens. According to the scientific and expert community, Russian PCR-based virus test systems are on par with proven imported analogues and even surpass them in certain respects. The government of the Russian Federation is faced with the serious task of mobilizing resources, not just within the healthcare system, but across all industrial capacities, integrating cutting-edge digital solutions to rapidly and accurately diagnose COVID-19 patients. No less important is the objective of supplying the country's medical organizations to ensure that there are no medicine or equipment deficits.

Discussion Questions

  • Is the government ready for a direct dialogue with producers of the medical equipment made essential during this pandemic?
  • How will shortening the time required to acquire a medical equipment production license affect access to those devices and the timelines for supplying medical organizations with them?
  • Are there enough educational programmes for doctors during this pandemic?
  • How can all medical personnel be kept similarly informed of modern prophylactic, diagnostic, and treatment methods?
  • How are unique regional characteristics being taken into account in the development of COVID-19 control measures?

Media partners

ip1.jpg  ip3.jpg

General partner of the event

 GE Healthcare Russia/CIS

GE Healthcare has been working in Russia/CIS for over 30 years, with a broad portfolio of products and services that is helping meet the region’s growing demand for high-tech medical equipment. The Moscow GE Healthcare Academy has educated thousands of doctors, specialists, and administrators on management best practices, innovative IT solutions, and hands-on training with advanced diagnostic equipment to improve patient outcomes. GE Healthcare’s growth strategy in Russia/CIS aims to empower our customers and partners in further improving the quality and accessibility of healthcare across the region. Find out more at



President and CEO GE Healthcare Russia/CI

Nina Kandelaki was born on October 15th, 1975 in Moscow. She is married, and has two children. She attended the Moscow State Medical University and graduated with a degree of GP in 2000. Then she continued her education in internship in Cardiology.

In 2002 Nina started her career in a science-led global healthcare company GlaxoSmithKline. In 2005 she joined Johnson & Johnson Medical Devices.

Since joining GE Healthcare in 2008, Nina held several senior positions including Regional Director for Moscow and Central Russia. From 2014 through 2016 being the Commercial Director for GE Healthcare Russia/CIS, Nina was responsible for the business development and growth strategy in the region.

In October 2016, Nina Kandelaki was appointed President and CEO of GE Healthcare Russia/CIS.

Back to news